WHO ICTRP trial
Clinical Research of allogeneic iPSC-RPE cell suspension transplantation for RPE…
JPRN-jRCTa050200122 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCTa050200122 |
|---|---|
| Public title | Clinical Research of allogeneic iPSC-RPE cell suspension transplantation for RPE impaired disease |
| Scientific title | allogeneic iPS cell-derived retinal pigmented epithelium (RPE) cell suspension for RPE impaired disease - aiPSC-RPE CS transplantation forRID |
| Primary sponsor | Kurimoto Yasuo |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 1-2 |
| Countries | Japan |
| Conditions | RPE impaired disease |
| Interventions | subretinal transplantation of human allogenic iPSC-RPE cell suspension (up to 50 micro L involving 250 thousand cells |
| Registration date | Jan 28, 2021 |
| Target size | 50 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: